Business Context and Reporting Period
Company: HealthSouth Corporation (Note: The input metadata references "Encompass Health Corp," but the filing text explicitly identifies the registrant as HealthSouth Corporation).
Reporting Period: Fiscal year ended December 31, 1999.
Business Overview: HealthSouth is the nation's largest provider of outpatient surgery and rehabilitative healthcare services. As of December 31, 1999, the company operated nearly 2,000 locations across 50 states, Puerto Rico, the United Kingdom, and Australia. Services include inpatient and outpatient rehabilitation, outpatient surgery centers, diagnostic centers, and occupational medicine centers. The company utilizes an "Integrated Service Model" to provide a continuum of care.
Key Financial Metrics (Year Ended Dec 31, 1999)
| Metric | 1999 Value | 1998 Value |
|---|---|---|
| Revenues | $4,072,107,000 | $4,006,074,000 |
| Net Income | $76,517,000 | $46,558,000 |
| Net Income Per Share (Diluted) | $0.18 | $0.11 |
| Operating Cash Flow | $704,511,000 | $636,132,000 |
| Total Assets | $6,832,334,000 | $6,762,897,000 |
| Long-Term Debt | $3,114,648,000 | $2,830,926,000 |
| Working Capital | $852,711,000 | $945,927,000 |
| Cash and Marketable Securities | $132,882,000 | $142,513,000 |
Revenue Mix (1999): Medicare (33.0%), Commercial (40.3%), Workers' Compensation (11.5%), All Other Payors (15.2%).
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased by 1.6% ($66 million) compared to 1998. Same-store revenue increased by 2.4%, driven by higher patient volumes (inpatient days +6.9%, outpatient visits +10.1%). However, revenue per unit of service declined significantly (e.g., revenue per surgical case decreased 5.1%).
- Profitability: Net income increased 64% to $76.5 million, primarily due to a reduction in non-recurring impairment charges compared to 1998. However, operating expenses as a percentage of revenue increased from 65.0% in 1998 to 69.7% in 1999.
- Provision for Doubtful Accounts: This line item surged from $112.2 million (2.8% of revenue) in 1998 to $342.7 million (8.4% of revenue) in 1999. Management attributed this to a more conservative estimation approach regarding the healthcare payor environment and the write-off of receivables from facilities closed in 1998.
- Impairment Charges: The company recorded $121.0 million in impairment and restructuring charges in 1999, a significant decrease from the $483.5 million recorded in 1998.
- Debt Levels: Long-term debt increased by approximately $284 million to $3.11 billion, largely due to increased borrowings under the revolving credit facility ($1.625 billion drawn at year-end).
Guidance, Outlook, Risks, and Unusual Items
Management Commentary and Outlook
- Spin-off Plan: In June 1999, the Board approved exploring a tax-free spin-off of inpatient operations. However, in September 1999, the Board indefinitely tabled this proposal due to capital market conditions and favorable developments in the prospective payment system for inpatient rehabilitation.
- Capital Expenditures: Management anticipates spending approximately $200 million to $250 million on maintenance/expansion and a similar amount on development and e-commerce initiatives over the next 12 months.
- Stock Repurchase: The company announced a plan to repurchase up to 70 million shares. As of December 31, 1999, approximately 36.3 million shares had been repurchased.
Risks and Contingencies
- Reimbursement Pressure: Substantially all revenues are derived from third-party payors. The company faces increasing pressure to control costs and limit reimbursement rate increases, particularly from Medicare and Medicaid.
- Regulatory Environment: The company is subject to extensive federal and state regulation, including licensure, Certificate of Need laws, and fraud/abuse statutes (e.g., Stark II, False Claims Act). Non-compliance could result in exclusion from Medicare/Medicaid or significant penalties.
- Legal Proceedings:
- Securities Litigation: Consolidated class action lawsuits allege misrepresentations regarding financial condition and the impact of the Balanced Budget Act of 1997. The company believes claims are without merit but cannot predict outcomes.
- Horizon/CMS Litigation: Includes a pending appeal of a Texas jury verdict (reduced to ~$11.2 million) regarding a nursing facility injury. The company expects insurance to cover the liability less a $250,000 retention.
- Patent Litigation: Fonar Corporation alleges patent infringement regarding MRI equipment features. The case is in the discovery phase.
Unusual Items
- 1999 Impairment: A $121 million charge was recorded in Q4 1999 based on a facility-by-facility review of long-term asset recoverability.
- Year 2000 Costs: Approximately $13.4 million in expenses related to Year 2000 remediation were included in corporate general and administrative expenses.
Investor Verification Checklist
- Allowance for Doubtful Accounts: Verify the rationale and sustainability of the sharp increase in the provision for doubtful accounts (from 2.8% to 8.4% of revenue) and its impact on future earnings.
- Reimbursement Rates: Monitor trends in revenue per patient day/visit, which declined in 1999, to assess the impact of managed care and government reimbursement pressures.
- Debt Covenants and Liquidity: Review the $1.75 billion revolving credit facility terms and the company's ability to service $3.1 billion in long-term debt given the high operating expense ratio.
- Legal Exposure: Track the status of the securities class action litigation and the Horizon/CMS Texas appeal, as adverse outcomes could be material.
- Asset Quality: Assess the remaining carrying value of intangible assets and goodwill following the $121 million impairment charge in 1999.